August 19, 2014
BENICIA, Calif.—InterHealth Nutraceuticals Inc. announced that it has acquired the 7-Keto ingredient from Humanetics Corporation. 7-Keto is a clinically tested, patented ingredient that helps maintain metabolic rate when dieting for greater weight loss and fat loss.
“7-Keto fits very nicely into InterHealth’s portfolio of science-based, branded, functional ingredients supported by robust clinical trial and safety data," said to Paul Dijkstra, president and CEO of InterHealth. “7-Keto® is sold to many of the industry’s most successful finished product brands and holds a strong position in the marketplace."
The transaction marks the second acquisition completed by InterHealth since it was acquired by Kainos Capital in November 2013.
You May Also Like
Beyond vaginal microbiota: Emotional well-being, gut health support – white paperNov 22, 2023
Custom 'biotic' solutions for digestive health – infographicDec 07, 2023
EPA and DHA help distance runners avoid muscle damage in sports nutrition studyDec 07, 2023
Generation Alpha emerges as a sophisticated and desirable target marketDec 07, 2023